NeuroPace (NPCE) Cash from Financing Activities (2020 - 2026)

NeuroPace's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$166000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 100.79% year-over-year to -$166000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 106.6% YoY), while the FY2025 annual figure was $19.6 million, up 352.97% from the prior year.
• Cash from Financing Activities was -$166000.0 for Q1 2026 at NeuroPace, down from $635000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $21.1 million in Q1 2025 to a low of -$1.9 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged $1.9 million across 5 years, with a median of $72000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities tumbled 25600.0% in 2023, then jumped 29216.67% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$138000.0 in 2022, then surged by 6052.17% to $8.2 million in 2023, then plunged by 89.68% to $848000.0 in 2024, then slipped by 25.12% to $635000.0 in 2025, then sank by 126.14% to -$166000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$166000.0 (Q1 2026), $635000.0 (Q4 2025), and -$235000.0 (Q3 2025), per Business Quant data.